$412 Million is the total value of SECTOR GAMMA AS's 31 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 6.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GILD | Sell | GILEAD SCIENCES INC | $45,033,876 | -12.0% | 542,773 | -8.9% | 10.92% | -6.7% |
| INCY | Buy | INCYTE CORP | $31,237,623 | -5.5% | 432,235 | +5.0% | 7.57% | +0.2% |
| BMY | Buy | BRISTOL-MYERS SQUIBB CO | $31,159,766 | +14.7% | 449,571 | +19.0% | 7.55% | +21.6% |
| CAH | Buy | CARDINAL HEALTH INC | $28,440,926 | +4.6% | 376,701 | +6.5% | 6.90% | +10.9% |
| MDT | Buy | MEDTRONIC PLC | $25,710,040 | +19.2% | 318,904 | +14.9% | 6.23% | +26.4% |
| BIIB | Buy | BIOGEN INC | $24,421,043 | +25.9% | 87,836 | +25.4% | 5.92% | +33.5% |
| ZBH | Buy | ZIMMER BIOMET HOLDINGS INC | $22,752,508 | +15.8% | 176,103 | +14.3% | 5.52% | +22.8% |
| LH | Buy | LABORATORY CORP AMER HLDGS | $18,678,229 | +6.5% | 81,415 | +9.3% | 4.53% | +12.9% |
| ANTM | Sell | ELEVANCE HEALTH INC | $16,451,542 | -32.9% | 35,779 | -25.1% | 3.99% | -28.8% |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $15,203,474 | -5.2% | 156,350 | +0.9% | 3.69% | +0.5% |
| CNC | Buy | CENTENE CORP DEL | $15,091,135 | -0.5% | 238,746 | +29.1% | 3.66% | +5.5% |
| EW | Sell | EDWARDS LIFESCIENCES CORP | $13,138,020 | +1.1% | 158,806 | -8.9% | 3.18% | +7.2% |
| BRKR | Sell | BRUKER CORP | $12,071,744 | -8.0% | 153,117 | -20.2% | 2.93% | -2.4% |
| QGEN | Buy | QIAGEN NV | $11,977,947 | +2.9% | 260,787 | +11.7% | 2.90% | +9.1% |
| CTLT | Buy | CATALENT INC | $9,889,421 | +299.5% | 150,501 | +173.6% | 2.40% | +323.7% |
| THC | Sell | TENET HEALTHCARE CORP | $9,817,788 | +2.7% | 165,227 | -15.7% | 2.38% | +8.9% |
| NUVA | Buy | NUVASIVE INC | $9,656,460 | +34.7% | 233,756 | +34.5% | 2.34% | +42.8% |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $8,124,722 | -40.4% | 162,397 | -44.9% | 1.97% | -36.8% |
| SGEN | Sell | SEAGEN INC | $7,288,920 | -46.6% | 36,000 | -66.1% | 1.77% | -43.4% |
| BAX | Sell | BAXTER INTL INC | $6,773,520 | -39.9% | 167,000 | -24.5% | 1.64% | -36.3% |
| BIO | Sell | BIO RAD LABS INCcl a | $6,522,815 | -3.0% | 13,617 | -14.8% | 1.58% | +2.9% |
| MRK | Sell | MERCK & CO INC | $5,974,118 | -73.0% | 56,153 | -71.8% | 1.45% | -71.4% |
| ILMN | Sell | ILLUMINA INC | $5,506,086 | -42.7% | 23,677 | -50.2% | 1.34% | -39.2% |
| ALNY | New | ALNYLAM PHARMACEUTICALS INC | $5,486,564 | – | 27,389 | +100.0% | 1.33% | – |
| IONS | Buy | IONIS PHARMACEUTICALS INC | $5,233,801 | -2.0% | 146,441 | +3.6% | 1.27% | +3.9% |
| ACAD | Buy | ACADIA PHARMACEUTICALS INC | $4,379,753 | +48.0% | 232,718 | +25.2% | 1.06% | +57.1% |
| RARE | Buy | ULTRAGENYX PHARMACEUTICAL IN | $4,261,908 | +102.1% | 106,282 | +133.5% | 1.03% | +114.3% |
| VIR | Buy | VIR BIOTECHNOLOGY INC | $3,386,832 | +49.0% | 145,545 | +62.1% | 0.82% | +57.9% |
| BNTX | Buy | BIONTECH SEsponsored ads | $3,307,832 | -7.2% | 26,554 | +11.9% | 0.80% | -1.6% |
| CVS | Sell | CVS HEALTH CORP | $2,846,816 | -29.7% | 38,310 | -11.8% | 0.69% | -25.5% |
| PTCT | Sell | PTC THERAPEUTICS INC | $2,659,647 | -19.6% | 54,906 | -36.7% | 0.64% | -14.8% |
| CI | Exit | CIGNA CORP NEW | $0 | – | -22,252 | -100.0% | -1.69% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BOSTON SCIENTIFIC CORP | 40 | Q1 2023 | 9.9% |
| BIO RAD LABS INC | 40 | Q1 2023 | 4.7% |
| BRISTOL-MYERS SQUIBB CO | 38 | Q3 2023 | 11.9% |
| BAXTER INTL INC | 34 | Q3 2023 | 12.7% |
| CARDINAL HEALTH INC | 34 | Q3 2023 | 8.1% |
| PERKINELMER INC | 33 | Q2 2021 | 6.3% |
| BIOGEN INC | 30 | Q3 2023 | 7.6% |
| ELEVANCE HEALTH INC | 30 | Q3 2023 | 5.6% |
| GILEAD SCIENCES INC | 29 | Q3 2023 | 14.0% |
| TENET HEALTHCARE CORP | 28 | Q3 2023 | 4.3% |
View SECTOR GAMMA AS's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-05 |
| 13F-HR | 2023-11-06 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-12 |
| 13F-HR/A | 2023-02-08 |
| 13F-HR | 2023-02-07 |
| 13F-HR | 2022-11-09 |
| 13F-HR | 2022-08-05 |
| 13F-HR | 2022-05-06 |
| 13F-HR | 2022-02-08 |
View SECTOR GAMMA AS's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.